The role of prophylactic octreotide in preventing ERCP induced pancreatitis
Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S385
DOI: 10.1055/s-0044-1783650 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von A. Garg.
Abstract (Originalsprache)
Aims
Octreotide is a synthetic somatostatin analogue with a longer half-life. Similarto somatostatin, octreotide is a potent inhibitor of pancreatic enzyme secretion and effect on thecontractility of sphincter of Oddi.
Methods
The present is a Double Blinded Randomised Control Study which was carried out in the Department of Gastroenterology and a total of 75 patients were taken which were divided into 2groups as Control (N=35) and Study group (N=40). 2 ml of normal saline and octreotide were given according to respective groups subcutaneously 1hour before procedure followed by 6 hour and 12 hours after ERCP and Serum Amylase and Lipasewere measured along with clinical features. The following protocol was followed based on previousstudies.
Results
The overall mean age of the study population including study and control group was 52years. Most common Indications for ERCP was Choledocholithiasis (50%) followed by malignantcause (30%), Benign Biliary Stricture (10-15%). Clinical and ERCP related risk factors according toESGE Guidelines were present in nearly 50-60%.Hyperamylasemia was present in Study group in 19 patients (47.5%) and amongst Control group in16 patients (45.7%).Incidence of Post ERCP Pancreatitis was present in only 5% in study group and 11.4% in controlgroup though statistically it was not significant (p=0.47)
Conclusions
Though, there is decrease in the incidence of Post ERCP pancreatitis in the groupreceiving octreotide, the same was not statistically significant as compared with the control (5% vs11.4%). Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Garg, A. (2024). The role of prophylactic octreotide in preventing ERCP induced pancreatitis. Endoscopy, 56(S 02 S 02), S385. https://doi.org/10.1055/s-0044-1783650
Vancouver
Garg A. The role of prophylactic octreotide in preventing ERCP induced pancreatitis. Endoscopy. 2024;56(S 02 S 02):S385. doi:10.1055/s-0044-1783650
BibTeX
@article{Garg2024,
author = {Garg, A.},
title = {The role of prophylactic octreotide in preventing ERCP induced pancreatitis},
journal = {Endoscopy},
year = {2024},
volume = {56},
number = {S 02 S 02},
pages = {S385},
doi = {10.1055/s-0044-1783650}
}
EUVIMED